Certoparin
- Generic Name
- Certoparin
- Drug Type
- Small Molecule
- Unique Ingredient Identifier
- V72OT3K19I
Overview
Certoparin is part of the heparins of low molecular weight that presents high activity against the coagulation factor Xa. It is normally used to prevent deep venous thrombosis.
Background
Certoparin is part of the heparins of low molecular weight that presents high activity against the coagulation factor Xa. It is normally used to prevent deep venous thrombosis.
Indication
Used in the prevention and treatment of venous thromboembolism (deep vein thrombosis and pulmonary embolism) and in the treatment of myocardial infarction.
Associated Conditions
- Deep Vein Thrombosis
- Thrombotic events caused by General Surgery
- Thrombotic events caused by Mobility decreased
- Thrombotic events caused by Stroke, Ischemic
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath